| Receipt no. | First name | Last name | Abstract title |
|---|
| 10029 | Hayato | Tada | A rare coincidence of Tangier disease and familial hypobetalipoproteinemia exhibiting combined hypolipidemia identified by whole exome sequencing |
| 10030 | Hayato | Tada | A rare coincidence of sitosterolemia and familial Mediterranean fever identified by whole exome sequencing |
| 10046 | Hayato | Tada | Whole Exome Sequencing in Familial Hypobetalipoproteinemia |
| 10081 | Hayato | Tada | Impact of impaired post-prandial lipoprotein metabolism in sitosterolemia |
| 10117 | Masato | Kajikawa | Endothelial Function is Impaired in Subjects with Increased Serum Triglyceride Levels |
| 10177 | Shunsuke | Watanabe | Impact Of n-3 Polyunsaturated Fatty Acids On Mortality Of Patients With Hospitalized Heart Failure Patients |
| 10197 | Tsuyoshi | Nozue | Effects of Statin Therapy on Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and Sortilin Levels |
| 10538 | Fumiyoshi | Tsunoda | Different Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid Supplementations on Peripheral Blood Mononuclear Cell Gene Expression |
| 10541 | Masahiro | Koseki | Phase I Clinical Trial of Transplantation Therapy with Allogeneic Adipose Tissue-derived Multi-lineage Progenitor Cells in Severe Familiar Hypercholesterolemia Patients |
| 10815 | Morihiro | Matsuda | Impact of Adipocytokines on Polyunsaturated Fatty Acid Profile And Estimated Delta-5-desaturase Activity in Patients with Coronary Artery Disease |
| 10964 | Takehiro | Hashikata | Ezetimibe Enhances and Stabilizes the Anticoagulant Effect of Warfarin |
| 11257 | Taketo | Sonoda | Impact of Lipoprotein(a) as residual risk on Clinical Outcomes in Patients with Coronary Artery Disease Treated with Statin After PCI. |
| 11291 | Takeshi | Okada | High-Performance Gel Permeation Chromatography Analysis Demonstrates Atherogenic Properties of Lipoproteins in Patients with Cholesteryl Ester Transfer Protein Deficiency |
| 11329 | Daisaku | Masuda | Selective Isolation and Proteomic Analysis of Intestine-derived Chylomicrons and Their Remnants in Human Serum |
| 11578 | Shunsuke | Sakai | The Association between Serum Lipoprotein (a) and the Coronary Plaque Vulnerability in the Culprit Lesion Determined by Optical Coherence Tomography. |
| 11623 | Toshihiko | Oshita | Endothelial Lipase Regulates Plasma HDL-C Concentration without Affecting Cholesterol Uptake Capacity of HDL Particle in Patients with Coronary Artery Disease. |
| 11626 | Kensuke | Matsushita | Effects of Moderate and Low Intensity Statin Therapy on Coronary Plaques in Patients with Acute Coronary Syndrome |
| 12089 | Koutaro | Yokote | Novel Treatment to Residual Risk, K-877, a Selective PPARα Modulator (SPPARMα), Added-on to Stable Pitavastatin Treatment in Japanese Dyslipidemic Patients |
| 12143 | Hidenori | Arai | Safety and Efficacy of K-877, a Selective PPARα Modulator (SPPARMα), in Combination with Stable Statin Treatment in Japanese Dyslipidemic Patients |
| 12196 | Shizuya | Yamashita | Effect on cholesterol efflux from macrophages with K-877, a selective PPARα modulator (SPPARMα): a randomized clinical trial in dyslipidemic patients |
| 12699 | Yusuke | Uemura | Lipoprotein(a) is a Significant Residual Risk for Adverse Vascular Events in Patients with Acute Myocardial Infarction |
| 12732 | Kenshi | Yamanaga | The Comparison of Statin Monotherapy and Statin-Ezetimibe Combined Therapy to Reduce LDL-C under 70mg/dl in Patients with Coronary Artery Disease. |
| 12842 | Amane | Harada | Cholesterol Uptake Capacity, a New Measure for High-Density Lipoprotein Functionality And Its Association with Incident Cardiovascular Events |
| 12992 | Kenshi | Hirayama | Impact of Paradoxical Decrease in High-Density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events |
| 13520 | Ryota | Teramoto | Comprehensive Approach Identifying Causative Mutations in Patients with Familial Hyperchylomicronemia Using a Next Generation Sequencing Panel |
| 13552 | Masayasu | Izuhara | High-density Lipoprotein Cholesterol Levels and Cardiovascular Outcomes in Japanese Patients after Percutaneous Coronary Intervention from the CREDO-Kyoto Registry Cohort-2 |
| 13558 | Hirokazu | Konishi | Lipoprotein(a) predicts long-term cardiovasculer events in patients after percutaneous coronary intervention |
| 20010 | Kwang K. | Koh | Rosuvastatin dose-dependently improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients |
